Free Trial

Tectonic Therapeutic Q1 2023 Earnings Report

Tectonic Therapeutic logo
$29.54 -1.29 (-4.18%)
As of 02/21/2025 04:00 PM Eastern

Tectonic Therapeutic EPS Results

Actual EPS
-$0.57
Consensus EPS
-$0.56
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

Tectonic Therapeutic Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tectonic Therapeutic Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Tectonic Therapeutic Earnings Headlines

Tectonic Therapeutic to Participate in March Investor Conferences
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. You see, I’ve recently uncovered a secret financial plot unfolding in Washington DC…
See More Tectonic Therapeutic Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tectonic Therapeutic? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tectonic Therapeutic and other key companies, straight to your email.

About Tectonic Therapeutic

Tectonic Therapeutic (NASDAQ:TECX), Inc. engages in discovery and development of therapeutic proteins & antibodies. The company was founded by Timothy A. Springer and Andrew Kruse in 2019 and is headquartered in Watertown, MA.

View Tectonic Therapeutic Profile

More Earnings Resources from MarketBeat